|Title:||Buspirone anti-anxiety method|
|Abstract:||Buspirone hydrochloride is an effective anti-anxiety agent for the palliative treatment of neurotic patients in which symptoms of anxiety are predominant at doses which are without observable effect in either normal individuals or psychotic patients.|
|Inventor(s):||Casten; George P. (Evansville, IN), McKinney; Gordon R. (Evansville, IN), Newton; Roger E. (Evansville, IN), Tompkins; E. Crosby (Evansville, IN), Weikel, Jr.; John H. (Mt. Vernon, IN)|
|Assignee:||Mead Johnson & Company (Evansville, IN)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Estimated Expiration||Supplementary Protection Certificate||SPC Country||SPC Expiration|
| This preview shows a limited data set|
Subscribe for full access, or try a Trial
The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.
Export unavailable in trial.
Subscribe for complete access.